Bevacizumab for metachronous metastatic colorectal cancer: a reflection of community based practice

BACKGROUND: Although the efficacy of bevacizumab has been established in patients with metastatic colorectal cancer (mCRC), population-based studies are needed to gain insight into the actual implementation of bevacizumab in daily practice. Since these studies are lacking for patients with metachron...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Razenberg, L. G. E. M., van Gestel, Y. R. B. M., de Hingh, I. H. J. T., Loosveld, O. J. L., Vreugdenhil, G., Beerepoot, L. V., Creemers, G. J., Lemmens, V. E. P. P.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4754889/
https://ncbi.nlm.nih.gov/pubmed/26882902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2158-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados